Alpna Seth - May 1, 2023 Form 3 Insider Report for Keros Therapeutics, Inc. (KROS)

Role: Director
Signature: /s/ Keith Regnante, Attorney-in-Fact
Stock symbol: KROS
Transactions as of: May 1, 2023
Transactions value $: $0
Form type: 3
Date filed: 5/3/2023, 04:44 PM
Previous filing: Oct 31, 2022
Next filing: Jun 2, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney